ALC (Medical supplies) Stock Valuation & Fair Value Mixed on our tests
ALC (Medical supplies) trades at a current P/E of 20.0, about 37% below its historical normal valuation, with a forward growth estimate of 13.6% and a PEG of 1.47. Analysts' one-year estimates have been hit 50% of the time. Priced at its historical normal P/E of 31.7 on the same blended earnings, the 2026-10-16 close of $66.18 corresponds to about $105 a share. This is a valuation reference, not a price target.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is ALC overvalued?
At a current P/E of 20.0 versus its historical normal P/E of 31.7, ALC trades about 37% below its typical valuation, with a PEG of 1.47 on 13.6% forward growth. tickerseer currently rates it mixed on our tests.
What is ALC's fair value and PEG?
ALC trades at a current P/E of 20.0 against a historical normal P/E of 31.7, a PEG of 1.47, and a forward growth estimate of 13.6%. Priced at its historical normal P/E of 31.7 on the same blended earnings, the 2026-10-16 close of $66.18 corresponds to about $105 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of ALC changed?
tickerseer's rating has been mixed on our tests since 2026-10-17.
Industry: Medical supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.